Liquid biopsy for infectious diseases: sequencing of cell-free plasma to detect pathogen DNA in patients with invasive fungal disease

Diagn Microbiol Infect Dis. 2018 Nov;92(3):210-213. doi: 10.1016/j.diagmicrobio.2018.06.009. Epub 2018 Jun 22.

Abstract

Diagnosis of life-threatening deep-seated infections currently requires invasive sampling of the infected tissue to provide a microbiologic diagnosis. These procedures can lead to high morbidity in patients and add to healthcare costs. Here we describe a novel next-generation sequencing assay that was used to detect pathogen-derived cell-free DNA in peripheral blood of patients with biopsy-proven invasive fungal infections. The noninvasive nature of this approach could provide rapid, actionable treatment information for invasive fungal infections when a biopsy is not possible.

Keywords: Diagnostic biopsy; Invasive fungal infection; Molecular diagnostics; Next-generation sequencing; Noninvasive.

MeSH terms

  • Adult
  • Aged
  • Cell-Free Nucleic Acids
  • Communicable Diseases / blood
  • Communicable Diseases / diagnosis*
  • Communicable Diseases / microbiology
  • DNA, Fungal / blood
  • DNA, Fungal / genetics
  • Female
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Invasive Fungal Infections / blood
  • Invasive Fungal Infections / diagnosis
  • Invasive Fungal Infections / microbiology
  • Liquid Biopsy* / methods
  • Male
  • Middle Aged
  • Molecular Diagnostic Techniques
  • Young Adult

Substances

  • Cell-Free Nucleic Acids
  • DNA, Fungal